Assignee
SYNTAXIN LTD
GB·17 granted patents·10 pending applications·340 citations·filing 2000–2014
Top patents by PatentIndex Score
27 records- 0198US7659092B2Fusion proteinsSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·58 cites·5 claims
- 0297US7892560B2Clostridial toxin derivatives able to modify peripheral sensory afferent functionsSYNTAXIN LTD·Filed 2007·Granted Feb 22, 2011·32 cites·4 claims
- 0397US7887810B2Clostridial toxin derivatives able to modify peripheral sensory afferent functionsSYNTAXIN LTD·Filed 2007·Granted Feb 15, 2011·32 cites·9 claims
- 0497US7658933B2Non-cytotoxic protein conjugatesSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·57 cites·4 claims
- 0597US7452543B2Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesicsSYNTAXIN LTD·Filed 2005·Granted Nov 18, 2008·49 cites·8 claims
- 0696US7727538B2Methods and compounds for the treatment of mucus hypersecretionSYNTAXIN LTD·Filed 2006·Granted Jun 1, 2010·22 cites·21 claims
- 0794US7897158B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2007·Granted Mar 1, 2011·11 cites·17 claims
- 0892US8940870B2Fusion proteinsSYNTAXIN LTD·Filed 2013·Granted Jan 27, 2015·11 cites·28 claims
- 0990US8372615B2Fusion proteinsSYNTAXIN LTD·Filed 2012·Granted Feb 12, 2013·7 cites·24 claims
- 1089US8012491B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2009·Granted Sep 6, 2011·6 cites·10 claims
- 1187US8017134B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2009·Granted Sep 13, 2011·5 cites·12 claims
- 1287US7470661B2Delivery of superoxide dismutase to neuronal cellsSYNTAXIN LTD·Filed 2005·Granted Dec 30, 2008·18 cites·5 claims
- 1385US8956847B2Fusion proteinsSYNTAXIN LTD·Filed 2013·Granted Feb 17, 2015·3 cites·25 claims
- 1485US7368532B2Constructs for delivery of therapeutic agents to neuronal cellsSYNTAXIN LTD·Filed 2000·Granted May 6, 2008·20 cites·8 claims
- 1583US9012195B2Non-cytotoxic protein conjugatesSYNTAXIN LTD·Filed 2013·Granted Apr 21, 2015·5 cites·21 claims
- 1681US9115350B2Carrier for targeting nerve cellsSYNTAXIN LTD·Filed 2013·Granted Aug 25, 2015·4 cites·22 claims
- 1762US2010034802A1Treatment of painSYNTAXIN LTD·Filed 2007·Application pending·0 cites
- 1861US2011262423A1Suppression of cancerSYNTAXIN LTD·Filed 2009·Application pending·0 cites
- 1958US2014348828A1Inhibition of secretion from non-neuronal cellsSYNTAXIN LTD·Filed 2014·Application pending·0 cites
- 2055US2015197739A1Fusion proteins and methods for treating, preventing or ameliorationg painSYNTAXIN LTD·Filed 2013·Application pending·0 cites
- 2154US2011091437A1Fusion proteinsSYNTAXIN LTD·Filed 2010·Application pending·0 cites
- 2251US2008249019A1Treatment of mucus hypersecretionSYNTAXIN LTD·Filed 2008·Application pending·0 cites
- 2351US2011152174A1Inhibition of secretion from non-neuronal cellsSYNTAXIN LTD·Filed 2011·Application pending·0 cites
- 2447US9170252B2Assay for assessment of endosomal transportSYNTAXIN LTD·Filed 2013·Granted Oct 27, 2015·0 cites·14 claims
- 2547US2011171191A1Suppression of neuroendocrine diseasesSYNTAXIN LTD·Filed 2009·Application pending·0 cites
- 2646US2014302006A1Suppression of neuroendocrine diseasesSYNTAXIN LTD·Filed 2014·Application pending·0 cites
- 2738US2011158973A1Suppression of cancersSYNTAXIN LTD·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →